 Connection
Qiang Fu to Protein Kinase Inhibitors
This is a "connection" page, showing publications Qiang Fu has written about Protein Kinase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.270 |
|
|
|
-
Xu J, Zhong Y, Qin M, Zhang Y, Ma Y, Hu B, Fu Q, Sun Y, Cheng M, Liu Y, Li J. Discovery and Administration Optimization of Novel Selective CDK9 Inhibitor, 1-7a-B1, for Improved Pharmacokinetics and Antitumor Efficacy In Vivo. J Med Chem. 2025 Jun 12; 68(11):11586-11605.
Score: 0.205
-
Boerma M, Fu Q, Wang J, Loose DS, Bartolozzi A, Ellis JL, McGonigle S, Paradise E, Sweetnam P, Fink LM, Vozenin-Brotons MC, Hauer-Jensen M. Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. Blood Coagul Fibrinolysis. 2008 Oct; 19(7):709-18.
Score: 0.065
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|